Nishtman Dizeyi (Former)
1 – 10 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A non-invasive 25-Gene PLNM-Score urine test for detection of prostate cancer pelvic lymph node metastasis
2024) In Prostate Cancer and Prostatic Diseases(
- Contribution to journal › Article
- 2021
-
Mark
Sialic acid as a biomarker studied in breast cancer cell lines in vitro using fluorescent molecularly imprinted polymers
(
- Contribution to journal › Article
-
Mark
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
(
- Contribution to journal › Article
- 2020
-
Mark
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
(
- Contribution to journal › Article
-
Mark
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
(
- Contribution to journal › Article
-
Mark
Discrimination between breast cancer cells and white blood cells by non-invasive measurements : Implications for a novel in vitro-based circulating tumor cell model using digital holographic cytometry
(
- Contribution to journal › Article
- 2019
-
Mark
Cell-based evidence regarding the role of FSH in prostate cancer
(
- Contribution to journal › Article
-
Mark
The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
(
- Contribution to journal › Article
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
(
- Contribution to journal › Article